Detalles de la búsqueda
1.
HIV MDR is still a relevant issue despite its dramatic drop over the years.
J Antimicrob Chemother
; 75(5): 1301-1310, 2020 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31976521
2.
SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV.
J Antimicrob Chemother
; 74(4): 1035-1043, 2019 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30561642
3.
Impact of transmitted HIV-1 drug resistance on the efficacy of first-line antiretroviral therapy with two nucleos(t)ide reverse transcriptase inhibitors plus an integrase inhibitor or a protease inhibitor.
J Antimicrob Chemother
; 73(9): 2480-2484, 2018 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29945251
4.
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016.
HIV Med
; 19(9): 619-628, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29932313
5.
Efficacy and safety of treatment simplification to atazanavir/ritonavirâ+âlamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study.
J Antimicrob Chemother
; 70(6): 1843-9, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25885326
6.
Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis.
Infection
; 42(4): 775-8, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24531907
7.
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group.
Infection
; 42(1): 61-71, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24146352
8.
Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients.
HIV Med
; 14(3): 136-44, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22994586
9.
Comparison of cognitive performance in HIV or HCV mono-infected and HIV-HCV co-infected patients.
Infection
; 41(6): 1103-9, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23839213
10.
Mid-dosing interval concentration of atazanavir and virological outcome in patients treated for HIV-1 infection.
HIV Med
; 11(5): 326-33, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20070407
11.
Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors.
J Antimicrob Chemother
; 64(3): 607-15, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19608581
12.
Viro-immunological efficacy and tolerability of dolutegravir-based regimens compared to regimens based on other integrase strand inhibitors, protease inhibitors or non-nucleoside reverse transcriptase inhibitors in patients with acute HIV-1 infection: A multicenter retrospective cohort study.
Int J Antimicrob Agents
; 54(4): 487-490, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31195121
13.
Genotypic resistance profile and clinical progression of treatment-experienced HIV type 1-infected patients with virological failure.
AIDS Res Hum Retroviruses
; 24(2): 149-54, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18240962
14.
Anal human papillomavirus in HIV-uninfected men who have sex with men: incidence and clearance rates, duration of infection, and risk factors.
Clin Microbiol Infect
; 22(12): 1004.e1-1004.e7, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27585942
15.
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010.
Clin Microbiol Infect
; 18(8): E299-304, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22536753
16.
Predictors of successful genotype-guided antiretroviral therapy in treatment-experienced individuals over calendar years: a cohort study.
J Clin Virol
; 46(3): 290-4, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19699675
17.
Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen.
HIV Med
; 9(3): 172-9, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18217998
Resultados
1 -
17
de 17
1
Próxima >
>>